Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
08/13/2009 | WO2009099176A1 Antibody capable of binding specifically to aβ-oligomer, and use thereof |
08/13/2009 | WO2009099149A1 Anti-d-amino acid monoclonal antibody, and immunological analysis method for d-amino acid using anti-d-amino acid monoclonal antibody |
08/13/2009 | WO2009099073A1 Modified trna containing non-natural nucleotide and use thereof |
08/13/2009 | US20090205076 Directed evolution of grg31 and grg36 epsp synthase enzymes |
08/13/2009 | US20090205061 Taste Receptors Of The T1R Family From Domestic Cat |
08/13/2009 | US20090205060 Sesquiterpene synthases from patchouli |
08/13/2009 | US20090204333 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
08/13/2009 | US20090203888 Isolated Photoprotein Aqdecay, and Its Use |
08/13/2009 | US20090203882 Novel microbial enzymes and their use |
08/13/2009 | US20090203878 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
08/13/2009 | US20090203641 Antibiotic compositions and related screening methods |
08/13/2009 | US20090203635 HXAAA01 Polynucleotides |
08/13/2009 | US20090203618 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |
08/13/2009 | US20090203585 Capreomycin derivatives and their use as antibacterials |
08/13/2009 | US20090203579 Glycopegylated Granulocyte Colony Stimulating Factor |
08/13/2009 | US20090203572 Method for in Vitro Molecular Evolution of Protein Function |
08/13/2009 | US20090203550 Methods of making glycomolecules with enhanced activities and uses thereof |
08/13/2009 | US20090203143 Trans-splicing mediated photodynamic therapy |
08/13/2009 | US20090203124 Mage-a3 peptides presented by hla-dr1 molecules |
08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
08/13/2009 | US20090203078 Process for producing polypeptide |
08/13/2009 | US20090203077 Method of producing factor viii proteins by recombinant methods |
08/13/2009 | US20090203076 Compositions and methods for increasing protein production |
08/13/2009 | US20090203075 Genes conferring herbicide resistance |
08/13/2009 | US20090203074 Bacillus Host Cell |
08/13/2009 | US20090203073 Gene Encoding G-Protein Coupled Receptor and Gene Product Thereof |
08/13/2009 | US20090203071 Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor |
08/13/2009 | US20090203070 Hyperphotosynthetic organisms |
08/13/2009 | US20090203069 comprising solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase; capturing and purifying Npro, Npro-mutants, Nprofusion proteins expressed as inclusion bodies under denaturing conditions or proteins with a high aggregation tendency using peptide affinity chromatography |
08/13/2009 | US20090203055 Compositions and methods for RNA interference with sialidase expression and uses thereof |
08/13/2009 | US20090203049 Beta integrin gene and protein |
08/13/2009 | US20090203046 Methods for identifying purkinje cells using the corl2 gene as a target |
08/13/2009 | US20090203036 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
08/13/2009 | US20090203024 Secreted protein called 36p6d5 characteristic of tumors |
08/13/2009 | US20090202997 Cell-Free In Vitro Transcription and Translation of Membrane Proteins into Tethered Planar Lipid Layers |
08/13/2009 | US20090202991 biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer |
08/13/2009 | US20090202680 Yeast strain and method for using the same to produce nicotinamide riboside |
08/13/2009 | US20090202675 Polypeptide |
08/13/2009 | US20090202595 Anti-pdef antibodies and uses thereof |
08/13/2009 | US20090202594 Anti-bacterial Vaccine Compositions |
08/13/2009 | US20090202580 Method for the preparation of specific antibodies against saccharidic antigens |
08/13/2009 | US20090202578 Surface proteins from coagulase-negative staphylococci and staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
08/13/2009 | US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use |
08/13/2009 | US20090202561 Novel raag10 cell surface target and a family of antibodies recognizing that target |
08/13/2009 | US20090202559 conjugated drug for drug targeting at pancreatic cancer cell; biodrugs as antitumor agent, anticarcinogenic agent; free of side effect |
08/13/2009 | US20090202558 TNFalpha-NEUTRALIZING ANTIBODIES |
08/13/2009 | US20090202556 Anti-claudin-4 antibody |
08/13/2009 | US20090202553 Antibodies against anthrax protective antigen |
08/13/2009 | US20090202550 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
08/13/2009 | US20090202549 Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses |
08/13/2009 | US20090202539 METHOD FOR TREATING CANCER USING ANTI-WNT2 MONOCLONAL ANTIBODIES AND siRNA |
08/13/2009 | US20090202532 High Functional Bispecific Antibody |
08/13/2009 | US20090202526 Agonist anti-trkc antibodies and methods using same |
08/13/2009 | US20090202511 Targeted protein replacement for the treatment of lysosomal storage disorders |
08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
08/13/2009 | US20090202502 Hepatic stellate cell specific promoter and uses thereof |
08/13/2009 | US20090202441 Compositions and methods to prevent cancer with cupredoxins |
08/13/2009 | US20090202438 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
08/13/2009 | US20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases |
08/13/2009 | CA2714413A1 Antibody capable of binding specifically to ab-oligomer, and use thereof |
08/13/2009 | CA2713178A1 Influenza b vaccines |
08/13/2009 | CA2712080A1 Breaking immunological tolerance with a genetically encoded unnatural amino acid |
08/12/2009 | EP2088431A1 METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN |
08/12/2009 | EP2088202A1 Translation and synthesis of polypeptide having nonnative structure at n-terminus and application thereof |
08/12/2009 | EP2088201A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
08/12/2009 | EP2088192A1 Lytic enzyme inhibitor, lysis inhibitor, inhibitor of degradation of poly- gamma-glutamic acid, and method for production of poly- gamma-glutamic acid |
08/12/2009 | EP2088188A1 Direct expression of peptides into culture media |
08/12/2009 | EP2088159A1 Antibody recognizing c-domain of midkine |
08/12/2009 | EP2088158A2 Monoclonal antibody against the CCR5 chemokine receptor |
08/12/2009 | EP2088153A1 Crystal of glutathione and process for production thereof |
08/12/2009 | EP2087908A1 Antibodies to opgl |
08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
08/12/2009 | EP2087103A1 Cancerous disease modifying antibodies |
08/12/2009 | EP2087002A2 Compositions and methods for binding sphingosine-1-phosphate |
08/12/2009 | EP2086584A2 Antibodies that bind cxcr7 epitopes |
08/12/2009 | EP2086528A2 Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases |
08/12/2009 | EP1911764B1 Growth-stimulating polypeptides for use in fish and crustaceans |
08/12/2009 | EP1896588B1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
08/12/2009 | EP1784503A4 Urine markers for detection of bladder cancer |
08/12/2009 | EP1546302B1 Methods for producing mammalian trypsins |
08/12/2009 | EP1465912B9 Chimeric tnf ligands |
08/12/2009 | EP1299414B1 Fluorescent proteins |
08/12/2009 | EP1255780B1 Methods for generating human monoclonal antibodies |
08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
08/12/2009 | EP1137941B1 Protein scaffolds for antibody mimics and other binding proteins |
08/12/2009 | CN101506359A Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses |
08/12/2009 | CN101503728A Method for extracting composite polypeptide liquid from mackerel bone |
08/12/2009 | CN101503727A Hyriopsis cumingii enzymolysis polypeptide, as well as preparation and application thereof |
08/12/2009 | CN101503726A Factor VII or VIIa-like molecules |
08/12/2009 | CN101503725A Technique for improving purity of diphtheria toxoid |
08/12/2009 | CN101503701A Preparations of human rhinopharynx tissue specific gene C10RF102 coding protein, polyclonal antibody and monoclonal antibody thereof |
08/12/2009 | CN101503697A Preparation of recombinant protein of human vascular endothelial cell growth inhibition factor rhVEGI-192A |
08/12/2009 | CN101503474A Human vascular endothelial cell growth inhibition factor jogged polypeptide, preparation thereof and use in targeted antineoplastic activity |
08/12/2009 | CN101503471A Monoclonal antibody of anti-rhabdovirus glucoprotein of mandarin fish, preparation and use thereof |
08/12/2009 | CN101503466A Birdsfoot trefoil root flower type and inflorescence structure regulating gene, coding protein and use thereof |
08/12/2009 | CN100526471C Method for preparing avenin ACE inhibiting peptide |
08/12/2009 | CN100526463C Methods for making Apo-2 ligand using divalent metal ions |
08/12/2009 | CN100526460C Transgenic ungulates having reduced prion protein activity and uses thereof |
08/12/2009 | CN100525649C Method for preparing microcapsule of enzyme hydrolysis object of poultry blood |